ABBVIE INC. vs. Tempest Therapeutics, Inc. Common Stock
ABBVIE INC. (ABBV) comes out ahead, leading on 4 of 5 compared factors.
Size & Scale
| ABBV | TPST | |
|---|---|---|
| Market Cap | $451.46 billion | $17.53 million |
| Revenue (TTM) | $64.39 billion | — |
| Net Income (TTM) | $6.32 billion | $-40,472,000 |
ABBV leads on 2 of 2 size & scale factors.
Valuation
| ABBV | TPST | |
|---|---|---|
| P/E Ratio | 72.17 | — |
| Price / Book | -76.68 | -16.08 |
| Price / Sales | 7.01 | — |
ABBV leads on 1 of 1 valuation factors.
Profitability
| ABBV | TPST | |
|---|---|---|
| Net Margin | 9.81% | — |
| Return on Equity | -107.29% | 3713.03% |
TPST leads on 1 of 1 profitability factors.
Dividend
| ABBV | TPST | |
|---|---|---|
| Dividend Yield | 2.71% | — |
| Payout Ratio | 195.48 | — |
ABBV and TPST split the dividend factors evenly.
Risk & Sentiment
| ABBV | TPST | |
|---|---|---|
| Short Interest | 0.85% | 1.07% |
ABBV leads on 1 of 1 risk & sentiment factors.
Dig deeper: ABBV overview, ABBV financials, TPST overview, TPST financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.